Upgrade for detailed insurance, legislation, and other documents analytics for individual cases; real-time analysis of the datasets from your EHR, CRM, ERP, or other software; and more Enterprise Features.
يمثل رمز HCPCS هذا 0.5 ملغ من pegfilgrastim-jmdb (Fulphila)، وهو بديل حيوي يستخدم لتقليل مخاطر العدوى لدى المرضى الذين يخضعون للعلاج الكيميائي المثبط للنقي.
2025 HCPCS code Q5108
Este código HCPCS representa 0,5 mg de pegfilgrastim-jmdb (Fulphila), un biosimilar que se usa para reducir el riesgo de infección en pacientes sometidos a quimioterapia mielosupresora.
2025 HCPCS code Q5106
<a href="../medical-coding/reference/ESRD" target="_blank" title="Medical Code ESRD 2025">Inyección, epoetina alfa-epbx, biosimilar (Retacrit) (para uso no relacionado con la ESRD), 1000 unidades</a>
2025 HCPCS code Q5108
이 HCPCS 코드는 골수억제 화학요법을 받는 환자의 감염 위험을 줄이기 위해 사용되는 바이오시밀러인 페그필그라스팀-jmdb (풀필라) 0.5mg을 나타냅니다.
2025 HCPCS code Q5108
Mã HCPCS này đại diện cho 0,5 mg pegfilgrastim-jmdb (Fulphila), một chất tương tự sinh học được sử dụng để giảm nguy cơ nhiễm trùng ở những bệnh nhân đang trải qua hóa trị ức chế tủy.
2025 HCPCS code Q5108
Ce code HCPCS représente 0,5 mg de pegfilgrastim-jmdb (Fulphila), un biosimilaire utilisé pour réduire le risque d'infection chez les patients subissant une chimiothérapie myélosuppressive.
2025 HCPCS code Q5108
Dieser HCPCS-Code steht für 0,5 mg Pegfilgrastim-jmdb (Fulphila), ein Biosimilar, das zur Verringerung des Infektionsrisikos bei Patienten eingesetzt wird, die sich einer myelosuppressiven Chemotherapie unterziehen.
Этот код HCPCS представляет собой 0,5 мг пегфилграстима-jmdb (Fulphila), биоаналога, используемого для снижения риска инфицирования у пациентов, проходящих миелосупрессивную химиотерапию.
2025 HCPCS code Q5105
注射剂，epoetin alfa-epbx，生物仿制药，（retacrit），100 单位
2025 HCPCS code Q5108
Ang code ng HCPCS na ito ay kumakatawan sa 0.5 mg ng pegfilgrastim-jmdb (Fulphila), isang biosimilar na ginagamit upang mabawasan ang panganib ng impeksyon sa mga pasyente na sumasailalim sa myelosuppressive therapy.
2025 HCPCS code Q5106
<a href="../medical-coding/reference/ESRD" target="_blank" title="Medical Code ESRD 2025">Injection, epoetin alfa-epbx, biosimilar, (Retacrit) (para sa hindi paggamit ng ESRD), 1000 yunit</a>
Инфликсимаб-DYYB для инъекций, биоаналогичный инфликсимабу, 10 мг
2025 HCPCS code Q5103
Infliximab-DYYB-Injektion, bioähnlich wie Infliximab, 10 mg
2025 HCPCS code Q5103
Infliximab-dyyb iniksyon, biosimilar sa infliximab, 10 mg
2025 HCPCS code Q5103
Infliximab-DYB injectable, biosimilaire à l'infliximab, 10 mg
2025 HCPCS code Q5103
인플릭시맙-Dyb 주사, 인플릭시맵과 바이오시밀러, 10mg
2025 HCPCS code Q5108
This HCPCS code represents 0.5 mg of pegfilgrastim-jmdb (Fulphila), a biosimilar used to reduce infection risk in patients undergoing myelosuppressive chemotherapy.
2025 HCPCS code Q5111
This HCPCS code represents 0.5 mg of pegfilgrastim-cbqv (Udenyca), a biosimilar to pegfilgrastim, used to reduce infection risk in cancer patients undergoing chemotherapy.
Continue with Personal Account
Thank you for exploring iFrame ♥ Please subscribe for unlimited access to our top-tier AI model, which directly supports our dedicated knowledge creators maintaining an ad-free internet experience.